SummaryTetherin is an interferon-induced protein whose expression blocks the release of HIV-1 and other enveloped viral particles. The underlying mechanism by which tetherin functions and whether it directly or indirectly causes virion retention are unknown. Here, we elucidate the mechanism by which tetherin exerts its antiviral activity. We demonstrate, through mutational analyses and domain replacement experiments, that tetherin configuration rather than primary sequence is critical for antiviral activity. These findings allowed the design of a completely artificial protein, lacking sequence homology with native tetherin, that nevertheless mimicked its antiviral activity. We further show that tetherin is incorporated into HIV-1 particles ...
Tetherin (CD317/BST2) is an interferon-induced membrane protein that inhibits the release of diverse...
Human cells possess an antiviral activity that inhibits the release of retrovirus particles, and oth...
more successful? Now, Sauter and colleagues show that, although pandemic HIV-1 M group has successfu...
SummaryTetherin is an interferon-induced protein whose expression blocks the release of HIV-1 and ot...
Tetherin is a cellular restriction factor that inhibits the release of HIV and other enveloped virus...
SummaryAntiviral proteins that recognize pathogen-specific or aberrantly located molecular motifs ar...
SummaryThe restriction factor BST-2/tetherin contains two membrane anchors employed to retain some e...
SummaryTetherin (BST2/CD317) restricts the release of enveloped viral particles from infected cells....
Host cells impose a broad range of obstacles to the replication of retroviruses. Tetherin (also know...
The IFN-inducible antiviral protein tetherin (or BST-2/CD317/HM1.24) impairs release of mature HIV-1...
SummaryThe tetherin/BST2/CD317 protein blocks the release of HIV-1 and other enveloped viruses by in...
Background: Tetherin (also known as BST-2, CD317, and HM1.24) is an interferon- induced protein that...
International audienceHIV-1 employs its structural proteins to orchestrate assembly and budding at t...
Mammalian cells are equipped with so-called “restriction factors” that suppress virus replication an...
Abstract Background Tetherin (BST-2/CD317/HM1.24) is an interferon (IFN)-inducible factor of the inn...
Tetherin (CD317/BST2) is an interferon-induced membrane protein that inhibits the release of diverse...
Human cells possess an antiviral activity that inhibits the release of retrovirus particles, and oth...
more successful? Now, Sauter and colleagues show that, although pandemic HIV-1 M group has successfu...
SummaryTetherin is an interferon-induced protein whose expression blocks the release of HIV-1 and ot...
Tetherin is a cellular restriction factor that inhibits the release of HIV and other enveloped virus...
SummaryAntiviral proteins that recognize pathogen-specific or aberrantly located molecular motifs ar...
SummaryThe restriction factor BST-2/tetherin contains two membrane anchors employed to retain some e...
SummaryTetherin (BST2/CD317) restricts the release of enveloped viral particles from infected cells....
Host cells impose a broad range of obstacles to the replication of retroviruses. Tetherin (also know...
The IFN-inducible antiviral protein tetherin (or BST-2/CD317/HM1.24) impairs release of mature HIV-1...
SummaryThe tetherin/BST2/CD317 protein blocks the release of HIV-1 and other enveloped viruses by in...
Background: Tetherin (also known as BST-2, CD317, and HM1.24) is an interferon- induced protein that...
International audienceHIV-1 employs its structural proteins to orchestrate assembly and budding at t...
Mammalian cells are equipped with so-called “restriction factors” that suppress virus replication an...
Abstract Background Tetherin (BST-2/CD317/HM1.24) is an interferon (IFN)-inducible factor of the inn...
Tetherin (CD317/BST2) is an interferon-induced membrane protein that inhibits the release of diverse...
Human cells possess an antiviral activity that inhibits the release of retrovirus particles, and oth...
more successful? Now, Sauter and colleagues show that, although pandemic HIV-1 M group has successfu...